Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

Solitary plasmacytoma of bone (SPB) is a localized tumor in the bone comprised of clonal plasma cells in the absence of other diagnostic features of multiple myeloma (MM), though patients may present with <10% clonal plasma cells in the bone marrow [ 1 ]. Most patients with SPB eventually develop overt MM, and numerous factors are associated with a shorter time to progression to active MM, including the presence of high-risk cytogenetics, abnormal serum free light chain ratio, minimal marrow involvement, and high-grade angiogenesis within the plasmacytoma [ 2 , 3 , 4 , 5 ].

Authors

Institutions

Publication Details

Journal
Blood Cancer Journal
Published
2026-11-16
DOI
https://doi.org/10.1038/s41408-026-01674-w
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

Saad Z. Usmani, Destin Carlisle, Benjamin Marshall Parsons, Elisabet Esteve Manasanch et al.
Blood Cancer Journal
Multiple Myeloma Research and Treatments
article

Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)

Saad Z. Usmani, Destin Carlisle, Benjamin Marshall Parsons, Elisabet Esteve Manasanch, Prashant Kapoor, Jose Eugenio Najera, Ilene A Galinsky, Douglas Weston Sborov, Shira Naomi Dinner, Philip McCarthy, Cesar Rodriguez, Paul Richardson, Lyle Goldman, Anuj Mahindra, James Omel, Yujia Wen, Tibor Kovacsovics, LeAnne Kennedy, Vera Suman
article en

Abstract

Solitary plasmacytoma of bone (SPB) is a localized tumor in the bone comprised of clonal plasma cells in the absence of other diagnostic features of multiple myeloma (MM), though patients may present with <10% clonal plasma cells in the bone marrow [ 1 ]. Most patients with SPB eventually develop overt MM, and numerous factors are associated with a shorter time to progression to active MM, including the presence of high-risk cytogenetics, abnormal serum free light chain ratio, minimal marrow involvement, and high-grade angiogenesis within the plasmacytoma [ 2 , 3 , 4 , 5 ].

Blood Cancer JournalVol. 16(1)
Atrium Health Wake Forest Baptist (US), Gundersen Health System (US), Roswell Park Comprehensive Cancer Center (US), Ascension (US), Mayo Clinic (US), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), University of Utah (US), Alliance for Clinical Trials in Oncology (US), Huntsman Cancer Institute (US), University of Chicago (US), City of Hope (US), Ascension Providence Hospital (US), Dana-Farber Cancer Institute (US), Cancer Centers of Southwest Oklahoma (US), Mayo Clinic in Arizona (US), Alliance Data (United States) (US), Dana-Farber/Harvard Cancer Center (US), Scripps MD Anderson Cancer Center (US), Tisch Cancer Institute (US), Icahn School of Medicine at Mount Sinai (US)
Roswell Park Cancer Institute, Celgene, Huntsman Cancer Institute, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute
Good health and well-being
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon